Pheniramine Maleate

CHEMBL1653 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
356.4 g/mol
LogP
Phase
4

Pheniramine maleate is the maleate salt form of pheniramine, a first-generation H1 antihistamine with anticholinergic and sedative properties used for allergic symptoms and nausea relief. See pheniramine for complete pharmacological details.

Peso Molecular

356,4000 g/mol

TPSA

90,70 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)/C=C\C(=O)O

InChI

InChI=1S/C16H20N2.C4H4O4/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16;5-3(6)1-2-4(7)8/h3-10,12,15H,11,13H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-

Molecular Formula

C20H24N2O4

HBD / HBA

2 / 6

Ligações Rotacionáveis

7

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Pheniramine maleate is the maleate salt form of pheniramine, a first-generation H1 antihistamine with anticholinergic and sedative properties used for allergic symptoms and nausea relief. See pheniramine for complete pharmacological details.

Yes, Pheniramine Maleate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1653. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5282139. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.